Article Information
History
- December 11, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Ernesto S. Nakayasu1,
- Lisa M. Bramer1,
- Charles Ansong1,
- Athena A. Schepmoes1,
- Thomas L. Fillmore1,
- Marina A. Gritsenko1,
- Therese R. Clauss1,
- Yuqian Gao1,
- Paul D. Piehowski2,
- Bryan A. Stanfill3,
- Dave W. Engel3,
- Daniel J. Orton1,
- Ronald J. Moore1,
- Wei-Jun Qian1,
- Salvatore Sechi4,
- Brigitte I. Frohnert5,
- Jorma Toppari6,
- Anette-G. Ziegler7,
- Åke Lernmark8,
- William Hagopian9,
- Beena Akolkar4,
- Richard D. Smith1,
- Marian J. Rewers5,
- Bobbie-Jo M. Webb-Robertson1,
- Thomas O. Metz1,* and
- the TEDDY Study Group#
- 1Biological Sciences Division, Pacific Northwest National Laboratory, Richland, WA, U.S.A.
- 2Environmental and Molecular Sciences Division, Pacific Northwest National Laboratory, Richland, WA, U.S.A.
- 3Computational Analytics Division, Pacific Northwest National Laboratory, Richland, WA, U.S.A.
- 4National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland, U.S.A.
- 5Barbara Davis Center for Diabetes, University of Colorado, Aurora CO, U.S.A.
- 6Department of Pediatrics, Turku University Hospital, Turku, Finland; and Institute of Biomedicine, Research Centre for Integrative Physiology and Pharmacology and Centre for Population Health Research, University of Turku, Turku, Finland
- 7Institute of Diabetes Research, Helmholtz Zentrum München, Munich, Germany; Forschergruppe Diabetes, Technical University of Munich, Klinikum Rechts der Isar, Munich, Germany; and Forschergruppe Diabetes e.V. at Helmholtz Zentrum München, Munich, Germany
- 8Unit for Diabetes and Celiac Disease, Wallenberg/CRC, Department of Clinical Sciences, Lund University/CRC, Skåne University Hospital SUS, 21428 Malmö, Sweden
- 9Pacific Northwest Diabetes Research Institute, Seattle, WA, U.S.A.
- ↵*Correspondence to Thomas O. Metz: Email: thomas.metz{at}pnnl.gov, Phone: +1 (509) 371-6581
Posted December 11, 2022.
Plasma protein biomarkers predict both the development of persistent autoantibodies and type 1 diabetes 6 months prior to the onset of autoimmunity: the TEDDY Study
